A detailed history of Dafna Capital Management LLC transactions in Merus N.V. stock. As of the latest transaction made, Dafna Capital Management LLC holds 412,573 shares of MRUS stock, worth $17.3 Million. This represents 5.3% of its overall portfolio holdings.

Number of Shares
412,573
Previous 409,445 0.76%
Holding current value
$17.3 Million
Previous $24.2 Million 14.92%
% of portfolio
5.3%
Previous 6.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$47.19 - $58.84 $147,610 - $184,051
3,128 Added 0.76%
412,573 $20.6 Million
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $1.21 Million - $1.83 Million
30,450 Added 8.03%
409,445 $24.2 Million
Q1 2024

May 15, 2024

SELL
$28.03 - $51.82 $2.13 Million - $3.93 Million
-75,875 Reduced 16.68%
378,995 $17.1 Million
Q4 2023

Feb 14, 2024

SELL
$20.06 - $28.66 $601,800 - $859,800
-30,000 Reduced 6.19%
454,870 $12.5 Million
Q3 2023

Nov 14, 2023

BUY
$20.13 - $27.29 $2.01 Million - $2.73 Million
100,000 Added 25.98%
484,870 $11.4 Million
Q2 2023

Aug 14, 2023

BUY
$18.33 - $27.18 $1.85 Million - $2.74 Million
100,872 Added 35.52%
384,870 $10.1 Million
Q1 2023

May 15, 2023

BUY
$14.25 - $20.5 $200,996 - $289,152
14,105 Added 5.23%
283,998 $5.23 Million
Q4 2022

Feb 14, 2023

SELL
$12.8 - $23.66 $89,600 - $165,620
-7,000 Reduced 2.53%
269,893 $4.18 Million
Q3 2022

Nov 14, 2022

BUY
$18.64 - $28.93 $260,997 - $405,077
14,002 Added 5.33%
276,893 $5.55 Million
Q2 2022

Aug 15, 2022

BUY
$13.98 - $29.25 $390,069 - $816,133
27,902 Added 11.87%
262,891 $5.95 Million
Q1 2022

May 16, 2022

BUY
$23.58 - $30.91 $209,861 - $275,099
8,900 Added 3.94%
234,989 $6.21 Million
Q4 2021

Feb 14, 2022

BUY
$20.0 - $32.29 $1.88 Million - $3.04 Million
94,140 Added 71.35%
226,089 $7.19 Million
Q3 2021

Nov 15, 2021

SELL
$16.48 - $27.23 $426,700 - $705,039
-25,892 Reduced 16.4%
131,949 $2.9 Million
Q1 2021

May 17, 2021

BUY
$16.14 - $29.11 $2.55 Million - $4.59 Million
157,841 New
157,841 $3.3 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.92B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.